bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Innate Pharma S.A. logo

    Innate Pharma S.A.

    IPHA | NASDAQ
    Chart Builder DCF Calculator
    $1.86
    -$0.04 (-2.11%)
    At close: Sep 21, 2026, 4:00 PM ET
    $1.85
    -$0.01 (-0.54%)
    After-hours: Sep 21, 2026, 5:06 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $174.66M
    Enterprise Value
    $152.86M
    Beta
    0.88
    Average Volume
    141.7K
    Shares Outstanding (Diluted)
    93.83M
    Shares Change YoY
    16.02%
    Institutional Ownership
    0.20%
    Exchange
    NASDAQ
    ISIN
    US45781K2042

    Price Performance

    Price Change 1M
    -15.8%
    Price Change 3M
    -1.6%
    Price Change 6M
    45.3%
    Price Change YTD
    2.2%
    Price Change 1Y
    1.6%
    Price Change 3Y
    -30.3%
    Price Change 5Y
    -72.2%
    1M CAGR (ann.)
    7.5%
    1Y CAGR (ann.)
    -4.1%
    5Y CAGR (ann.)
    -19.9%
    All-Time CAGR
    -15.6%

    Valuation

    PE Ratio
    -3.13
    Forward PE
    40.01
    PEG Ratio
    -0.42
    Forward PEG
    0.14
    PS Ratio
    138.14
    Forward PS
    2.10
    PB Ratio
    -3.78
    P/FCF Ratio
    -3.33
    P/Adj. FCF Ratio
    -3.33
    P/OCF Ratio
    -3.54
    EV/Sales
    141.02
    EV/EBIT
    -2.87
    EV/EBITDA
    -2.91
    EV/FCF
    -3.40
    Earnings Yield
    -31.4%
    FCF Yield
    -29.4%
    Adj. FCF Yield
    -29.4%

    Financial Health

    Net Debt
    €9.26M
    Total Debt
    €10.83M
    Cash & Short-Term Investments
    €10.89M
    Total Assets
    €34.71M
    Current Ratio
    0.60
    Quick Ratio
    0.60
    Debt / Equity Ratio
    -0.50
    Debt / EBITDA
    -0.21
    Debt / FCF
    -0.24
    OCF / Debt
    -4.13
    Interest Coverage
    -17.47
    Altman Z-Score
    -22.62
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    1770.3%
    Operating Profit Margin
    -4598.8%
    EBITDA Margin
    -4977.0%
    Net Profit Margin
    -4554.3%
    FCF Margin
    -4142.3%
    Adj. FCF Margin
    -4142.3%
    SBC / Revenue
    0.0%
    SBC Impact (per share)
    N/A

    Returns

    Return on Assets
    -136.7%
    Return on Equity
    152.6%
    Return on Invested Capital
    -380.7%
    Return on Capital Employed
    -2860.4%
    Return on Tangible Assets
    -136.7%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -72.8%
    Revenue CAGR 5Y
    -51.7%
    Revenue CAGR 10Y
    -11.7%
    EPS CAGR 3Y
    -26.8%
    EPS CAGR 5Y
    12.3%
    EPS CAGR 10Y
    -6.0%
    FCF CAGR 3Y
    -28.7%
    FCF CAGR 5Y
    21.9%
    FCF CAGR 10Y
    -14.5%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    6
    EPS Growth Next 3Y
    46.4%
    Revenue Growth Next 3Y
    370.6%
    Earnings Date
    Sep 16, 2026
    EPS Estimate (next Q)
    -$0.34
    EPS Growth Est (next Q)
    N/A
    Revenue Est (next Q)
    $7.27M
    Revenue Growth Est (next Q)
    30.7%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $6.67
    Price Target Upside
    258.6%

    Cash Flow

    Operating Cash Flow
    €-44.72M
    Free Cash Flow
    €-44.9M
    Adj. Free Cash Flow
    €-44.9M
    FCF Per Share
    -$0.46
    OCF Per Share
    -$0.45
    OCF/S Ratio
    -4091.7%

    Income Statement

    Revenue
    €1.08M
    Gross Profit
    €18.45M
    Operating Income
    €-49.85M
    EBITDA
    €-52.55M
    Net Income
    €-47.51M
    EPS (Diluted)
    -$0.51
    Revenue / Employee
    $6.65K
    Profit / Employee
    $-291.5K
    Employees
    163

    © 2026 bestshares.com. All rights reserved.